Gabriel Oller-Gallo
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapy.
Journal: International review of cell and molecular biology
Published: July 23, 2025
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
Journal: Experimental hematology & oncology
Published: December 13, 2023
Cytotoxicity of poly-guanidine in medulloblastoma cell lines.
Journal: Investigational new drugs
Published: June 05, 2023
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.
Journal: Cellular and molecular life sciences : CMLS
Published: January 13, 2022
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
Journal: International journal of molecular sciences
Published: October 26, 2021
PPM1D Is a Therapeutic Target in Childhood Neural Tumors.
Journal: Cancers
Published: October 24, 2021
Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 19, 2021
Transforming growth factor beta (TGF-β) activity in immuno-oncology studies.
Journal: Methods in enzymology
Published: March 18, 2020
Last Updated: 09/26/2026